Abingdon Health PLC
FINPROM Findings
1“discount of approximately 0.8 per cent... Placing Shares will represent approximately 22 per cent. of the Enlarged Share Capital... accelerate expansion operations in the USA... major contract wins”
Minimal discount (0.8%), moderate dilution (22%), clear use-of-proceeds tied to contract wins and US expansion, and a retail offer via BookBuild to mitigate pre-emption dilution. This is a well-structured fundraise with proportionate terms.
RNS Announcements
1Proposed Placing and Retail Offer
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN ABINGDON…
Board of Directors
6| Name | Role | Appointed | Status |
|---|---|---|---|
| Dr Christopher William Hand | Executive Chairman | 2008-01-17 | active |
| Mary Geraldine Tavener | Non-executive Director | 2020-10-26 | active |
| Sarah Katherine Brenner | Non-Executive Director | 2025-04-01 | active |
| Thomas Edward Hayes | Director | 2025-01-06 | active |
| Thomas Edward Hayes | Director | 2025-03-24 | active |
| Tom Hayes | Chief Financial Officer | — | active |